Track topics on Twitter Track topics that are important to you
The inhaler combines fluticasone furoate, umeclidinium and vilanterol as part of maintenance treatment for the condition in those who do not respond suitably to a combination of an inhaled corticosteroid and a long-acting beta2-agonist.
Original Article: GSK receives positive opinion for triple-therapy inhalerNEXT ARTICLE
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...
Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...